Literature DB >> 2138576

Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes.

A Ceriello1, D Giugliano, A Quatraro, E Marchi, M Barbanti, P Lefebvre.   

Abstract

In this study, total protein S (PS) immunological levels, free-PS and C4b-binding-protein (C4bBP) concentrations, and PS functional activity were investigated in insulin-dependent (type I) diabetic patients and compared with nondiabetic subjects. Mean total PS antigen concentration was not different between diabetic patients and nondiabetic subjects, whereas free-PS levels and PS functional activity were significantly reduced in diabetic patients. C4bBP was increased in diabetic patients and correlated with HbA1 levels. This study shows that type I diabetic patients have depressed free PS and PS activity despite the presence of normal total PS concentration and suggests that this phenomenon is probably linked to the increase of circulating C4bBP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138576     DOI: 10.2337/diab.39.4.447

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

Review 1.  Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.

Authors:  A Ceriello
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

2.  Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.

Authors:  P Knöbl; G Schernthaner; C Schnack; P Pietschmann; A Griesmacher; R Prager; M Müller
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

3.  Diabetic ketoacidosis-associated stroke in children and youth.

Authors:  Jennifer Ruth Foster; Gavin Morrison; Douglas D Fraser
Journal:  Stroke Res Treat       Date:  2011-02-22

4.  Derangement of protein S and C4b-binding protein levels as acquired thrombophilia in HIV-infected adult Nigerians.

Authors:  Fatai O Bello; Alani S Akanmu; Titilope A Adeyemo; Bukunmi M Idowu; Prosper Okonkwo; Phyllis J Kanki
Journal:  South Afr J HIV Med       Date:  2021-08-23       Impact factor: 2.744

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.